Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Emerson Jorden currently holds 2,061,227 shares of CYTOMEDIX INC (GTF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Emerson Jorden has been a net buyer of GTF stock. They have purchased $2.3M and sold $713.6K worth of shares.
David Emerson Jorden's most recent insider trade was on Jun 30, 2026, when they sold 162,500 shares at $0.00 per share.
David Emerson Jorden serves as Executive at CYTOMEDIX INC (GTF). They have executed 174 insider transactions totaling $3.0M over their tenure at the company.
David Emerson Jorden holds the position of Executive at CYTOMEDIX INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
David Emerson Jorden has shown a buying trading pattern, with $2.3M in total purchases and $713.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David Emerson Jorden was on Nov 28, 2025, when they sold $300.0K worth of AURX shares. This transaction involved 200,000 shares at $1.50 per share.
David Emerson Jorden currently owns 2,061,227 shares of CYTOMEDIX INC (GTF), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Emerson Jorden's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Emerson Jorden has 174 Form 4 filings on record as an insider at CYTOMEDIX INC.
Set alerts for David Emerson Jorden and 40,000+ other insiders.